{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:30:41Z","timestamp":1790811041657,"version":"4.1.0"},"reference-count":20,"publisher":"BMJ","issue":"12","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Retina UK and Fight for Sight","award":["GR586 [RP Genome Project - UK IRDC]"],"award-info":[{"award-number":["GR586 [RP Genome Project - UK IRDC]"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200990\/Z\/16\/Z"],"award-info":[{"award-number":["200990\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224643\/Z\/21\/Z"],"award-info":[{"award-number":["224643\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"French Albinism Association (Genespoir) and the French National Research Agency","award":["ANR-21-CE17-0041-01"],"award-info":[{"award-number":["ANR-21-CE17-0041-01"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["CL-2017-06-001"],"award-info":[{"award-number":["CL-2017-06-001"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Med Genet"],"accepted":{"date-parts":[[2023,5,12]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Albinism is a clinically and genetically heterogeneous group of conditions characterised by visual abnormalities and variable degrees of hypopigmentation. Multiple studies have demonstrated the clinical utility of genetic investigations in individuals with suspected albinism. Despite this, the variation in the provision of genetic testing for albinism remains significant. One key issue is the lack of a standardised approach to the analysis of genomic data from affected individuals. For example, there is variation in how different clinical genetic laboratories approach genotypes that involve incompletely penetrant alleles, including the common, \u2018hypomorphic\u2019 <jats:italic>TYR<\/jats:italic> c.1205G&gt;A (p.Arg402Gln) [rs1126809] variant. Here, we discuss the value of genetic testing as a frontline diagnostic tool in individuals with features of albinism and propose a practice pattern for the analysis of genomic data from affected families.<\/jats:p>","DOI":"10.1136\/jmg-2022-109088","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T13:20:33Z","timestamp":1689600033000},"page":"1245-1249","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["A multilayered approach to the analysis of genetic data from individuals with suspected albinism"],"prefix":"10.1136","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0986-4123","authenticated-orcid":false,"given":"Panagiotis I.","family":"Sergouniotis","sequence":"first","affiliation":[{"name":"Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"},{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL- EBI), Wellcome Genome Campus, Cambridge, UK"},{"name":"Manchester Centre for Genomic Medicine, Saint Mary\u2019s Hospital, Manchester University NHS Foundation Trust, Manchester, UK"},{"name":"Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5788-392X","authenticated-orcid":false,"given":"Vincent","family":"Michaud","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France"},{"name":"INSERM U1211, Rare Diseases, Genetics and Metabolism, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eulalie","family":"Lasseaux","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Campbell","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Saint Mary\u2019s Hospital, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Plaisant","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Javerzat","sequence":"additional","affiliation":[{"name":"INSERM U1211, Rare Diseases, Genetics and Metabolism, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan","family":"Birney","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL- EBI), Wellcome Genome Campus, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Ramsden","sequence":"additional","affiliation":[{"name":"Manchester Centre for Genomic Medicine, Saint Mary\u2019s Hospital, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme C.","family":"Black","sequence":"additional","affiliation":[{"name":"Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK"},{"name":"Manchester Centre for Genomic Medicine, Saint Mary\u2019s Hospital, Manchester University NHS Foundation Trust, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Arveiler","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, University Hospital of Bordeaux, Bordeaux, France"},{"name":"INSERM U1211, Rare Diseases, Genetics and Metabolism, University of Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"2025101714132433000_60.12.1245.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2018.08.003"},{"key":"2025101714132433000_60.12.1245.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2022.101091"},{"key":"2025101714132433000_60.12.1245.3","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/s41436-020-0867-5","article-title":"BLOC1S5 pathogenic variants cause a new type of Hermansky-Pudlak syndrome","volume":"22","author":"Pennamen","year":"2020","journal-title":"Genet Med"},{"key":"2025101714132433000_60.12.1245.4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41436-020-00997-8","article-title":"Dopachrome tautomerase variants in patients with oculocutaneous albinism","volume":"23","author":"Pennamen","year":"2021","journal-title":"Genet Med"},{"key":"2025101714132433000_60.12.1245.5","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12688"},{"key":"2025101714132433000_60.12.1245.6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0566-4","article-title":"Common genetic variants contribute to risk of rare severe neurodevelopmental disorders","volume":"562","author":"Niemi","year":"2018","journal-title":"Nature"},{"key":"2025101714132433000_60.12.1245.7","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/s41588-022-01219-4","article-title":"Rare and common autism risk variants converge across 16p","volume":"54","author":"Won","year":"2022","journal-title":"Nat Genet"},{"key":"2025101714132433000_60.12.1245.8","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31392-3","article-title":"The contribution of common regulatory and protein-coding TYR variants to the genetic architecture of albinism","volume":"13","author":"Michaud","year":"2022","journal-title":"Nat Commun"},{"key":"2025101714132433000_60.12.1245.9","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30"},{"key":"2025101714132433000_60.12.1245.10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41431-021-00903-z","article-title":"Stepwise ABC system for classification of any type of genetic variant","volume":"30","author":"Houge","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"2025101714132433000_60.12.1245.11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115064"},{"key":"2025101714132433000_60.12.1245.12","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-312729"},{"key":"2025101714132433000_60.12.1245.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41525-021-00275-9","article-title":"Evidence that the Ser192Tyr\/Arg402Gln in cis tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B)","volume":"7","author":"Lin","year":"2022","journal-title":"NPJ Genom Med"},{"key":"2025101714132433000_60.12.1245.14","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00426","article-title":"Long-read sequencing emerging in medical genetics","volume":"10","author":"Mantere","year":"2019","journal-title":"Front Genet"},{"key":"2025101714132433000_60.12.1245.15","doi-asserted-by":"publisher","DOI":"10.1038\/S41436-019-0722-8"},{"key":"2025101714132433000_60.12.1245.16","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-019-0430-6","article-title":"Genetic analyses of human fetal retinal pigment epithelium gene expression suggest ocular disease mechanisms","volume":"2","author":"Liu","year":"2019","journal-title":"Commun Biol"},{"key":"2025101714132433000_60.12.1245.17","first-page":"38","article-title":"Regulation of the human tyrosinase gene in retinal pigment epithelium cells: The significance of transcription factor Orthodenticle Homeobox 2 and its polymorphic binding site","volume":"18","author":"Reinisalo","year":"2012","journal-title":"Mol Vis"},{"key":"2025101714132433000_60.12.1245.18","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12253"},{"key":"2025101714132433000_60.12.1245.19","first-page":"103","article-title":"A polymorphism of the human tyrosinase gene is associated with temperature-sensitive enzymatic activity","volume":"1","author":"Tripathi","year":"1991","journal-title":"Gene Expr"},{"key":"2025101714132433000_60.12.1245.20","doi-asserted-by":"publisher","DOI":"10.1096\/fj.01-0216com"}],"container-title":["Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jmg-2022-109088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:13:37Z","timestamp":1760735617000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmg.bmj.com\/lookup\/doi\/10.1136\/jmg-2022-109088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,11,27]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/jmg-2022-109088"],"URL":"https:\/\/doi.org\/10.1136\/jmg-2022-109088","relation":{},"ISSN":["0022-2593","1468-6244"],"issn-type":[{"value":"0022-2593","type":"print"},{"value":"1468-6244","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}